Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Small conductance calcium-activated potassium channel 1 (SK1) is a calcium-activated potassium channel encoded by the KCNN1 gene. SK channels are tetrameric complexes, each formed from four alpha subunits and activated by intracellular calcium binding to calmodulin. Activation leads to membrane hyperpolarization, inhibiting further cell firing and regulating neuronal excitability and synaptic plasticity. They are expressed throughout the central nervous system, cardiac tissue, and other excitable cells. Altered expression or function has been implicated in several conditions, including chronic atrial fibrillation and neurodevelopmental/psychiatric disorders.
Modulation of potassium ion flow through calcium-activated channels, leading to membrane hyperpolarization and altered cellular excitability.
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Small Conductance Calcium-Activated Potassium Channel 1 (SK1).